Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS)

Historical Holders from Q1 2021 to Q3 2025

Symbol
PHVS on Nasdaq
CUSIP
N69605108
Type / Class
Equity / Ordinary Shares, Euro 0.12 par value per share
Shares outstanding
62.3M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
57.8M
Holdings value
$1.44B
% of all portfolios
0.022%
Grand Portfolio weight change
+0%
Number of holders
83
Number of buys
66
Number of sells
-14
Average Value change %
+0%
Average buys %
+0.003%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Venrock Healthcare Capital Partners III, L.P. 3.8% $51.4M 2.05M Venrock Healthcare Capital Partners III, L.P. Jun 30, 2025
Bain Capital Life Sciences Fund, L.P. 3% $46.6M 1.87M Bain Capital Life Sciences Fund, L.P. Sep 30, 2025

Institutional Holders of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 57.8M $1.44B +$236M $24.95 83
2025 Q2 45M $793M +$1.81M $17.60 60
2025 Q1 44.9M $706M +$4.13M $15.70 52
2024 Q4 44.6M $856M -$7.19M $19.17 54
2024 Q3 45M $834M +$34.1M $18.52 51
2024 Q2 43M $809M +$10.7M $18.80 36
2024 Q1 42.4M $980M +$36.7M $23.11 35
2023 Q4 40.2M $1.13B +$314M $28.05 35
2023 Q3 29.1M $607M +$4.47M $20.87 21
2023 Q2 28.9M $442M +$110M $15.14 21
2023 Q1 21.8M $174M +$3.76M $8.06 21
2022 Q4 21.3M $240M -$1.83M $11.25 25
2022 Q3 22.3M $174M -$317K $7.67 21
2022 Q2 22.4M $494M +$14.9M $22.10 20
2022 Q1 21.7M $397M +$839K $18.14 22
2021 Q4 21.6M $321M -$1.7M $14.39 22
2021 Q3 21.6M $380M -$6.83M $17.73 25
2021 Q2 22M $406M -$1.44M $18.62 28
2021 Q1 22M $617M +$617M $27.99 33